4265-2343 Screening compound: 1-[2-nitro-4-(trifluoromethyl)phenyl]-4-{2-[(4-phenyl-1,2,5-oxadiazol-3-yl)oxy]ethyl}piperazine

4265-2343 Screening compound: 1-[2-nitro-4-(trifluoromethyl)phenyl]-4-{2-[(4-phenyl-1,2,5-oxadiazol-3-yl)oxy]ethyl}piperazine
4265-2343 Screening compound: 1-[2-nitro-4-(trifluoromethyl)phenyl]-4-{2-[(4-phenyl-1,2,5-oxadiazol-3-yl)oxy]ethyl}piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound 4265-2343
1-[2-nitro-4-(trifluoromethyl)phenyl]-4-{2-[(4-phenyl-1,2,5-oxadiazol-3-yl)oxy]ethyl}piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

4265-2343

Molecular Formula

C21H20F3N5O4 (C21 H20 F3 N5 O4)

Compound Name

1-[2-nitro-4-(trifluoromethyl)phenyl]-4-{2-[(4-phenyl-1,2,5-oxadiazol-3-yl)oxy]ethyl}piperazine

IUPAC name

1-[2-nitro-4-(trifluoromethyl)phenyl]-4-{2-[(4-phenyl-125-oxadiazol-3-yl)oxy]ethyl}piperazine

SMILES

[O-][N+](c(cc(C(F)(F)F)cc1)c1N1CCN(CCOc2nonc2-c2ccccc2)CC1)=O

InChI

InChI=1S/C21H20F3N5O4/c22-21(23,24)16-6-7-17(18(14-16)29(30)31)28-10-8-27(9-11-28)12-13-32-20-19(25-33-26-20)15-4-2-1-3-5-15/h1-7,14H,8-13H2

InChI Key

RCPYVDUQMFJEDZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01907123

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

463.42

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.806

Distribution Coefficient, logD

4.543

Water Solubility, LogSw

-4.96

Polar Surface Area

84.281

Acid Dissociation Constant (pKa)

27.61

Base Dissociation Constant (pKb)

7.32

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

4265-2343 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with 4265-2343 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 4265-2343?
Check Price and Availability of 4265-2343, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 4265-2343 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 4265-2343
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 4265-2343
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 4265-2343 available by request